Zobrazeno 1 - 10
of 108
pro vyhledávání: '"V. Mcnally"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Naomi K. Tepper, John R. Su, Emily Jane Woo, Kevin C. Ess, Veronica V. McNally, Meghna Alimchandani, Danielle Moulia, Lauri E. Markowitz, Tom T. Shimabukuro, Adamma Mba-Jonas, Hannah G. Rosenblum, Kayla E. Hanson, Stephen C. Hadler, H. Keipp Talbot, Melinda Wharton, Jose R. Romero, Sarah Mbaeyi, Narayan Nair, Matthew F. Daley, Grace M. Lee, Sara E. Oliver, Nicola P. Klein
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 70:1094-1099
In December 2020, the Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUAs) for Pfizer-BioNTech and Moderna COVID-19 vaccines, and in February 2021, FDA issued an EUA for the Janssen (Johnson & Johnson) COVID-19 vaccine. After
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f99c3d2e19b36360e407b2eaaa0550b
https://doi.org/10.15585/mmwr.mm7032e4
https://doi.org/10.15585/mmwr.mm7032e4
Autor:
Lauri E. Markowitz, Gayle E Langley, Heather M. Scobie, Melinda Wharton, Megan J. Wallace, Julia W. Gargano, Tom T. Shimabukuro, Karen R. Broder, Stephen C. Hadler, H. Keipp Talbot, Matthew F. Daley, Julianne Gee, Sara E. Oliver, Eric Weintraub, John R. Su, Danielle Moulia, Matthew E. Oster, Veronica V. McNally, Jose R. Romero, Grace M. Lee
Publikováno v:
Morbidity and Mortality Weekly Report
In December 2020, the Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUAs) for the Pfizer-BioNTech COVID-19 (BNT162b2) vaccine and the Moderna COVID-19 (mRNA-1273) vaccine,† and the Advisory Committee on Immunization Practi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0678e1b43dc9a8db130bd59ba8fc5f3c
https://doi.org/10.15585/mmwr.mm7027e2
https://doi.org/10.15585/mmwr.mm7027e2
Autor:
Jose R. Romero, Amy Blain, Grace M. Lee, Danielle Moulia, Heather M. Scobie, Julia W. Gargano, Megan J. Wallace, Alice Guh, Veronica V. McNally, Jessica R. MacNeil, Stephen C. Hadler, John R. Su, Beth P. Bell, Matthew F. Daley, Sara E. Oliver, H. Keipp Talbot, Karen R. Broder
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 70:651-656
On February 27, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Janssen COVID-19 (Ad.26.COV2.S) vaccine (Janssen Biotech, Inc., a Janssen Pharmaceutical company, Johnson & Johnson; New Brunswick, New J
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f717a7eb3e4de403cd16e9706240d62f
https://doi.org/10.15585/mmwr.mm7017e4
https://doi.org/10.15585/mmwr.mm7017e4
Autor:
Ralf Gutzmer, Grant A. McArthur, Piotr Rutkowski, Daniil Stroyakovskiy, Anne Uyei, Karl D. Lewis, Kuan Chieh Huang, Thomas Eigentler, Caroline Robert, Lev V. Demidov, Rodrigo Perez Pereira, Georgy M. Manikhas, Paolo A. Ascierto, V. McNally, Svetlana Protsenko, Yibing Yan, Helen Gogas
Publikováno v:
The Lancet. 395:1835-1844
Summary Background IMspire150 aimed to evaluate first-line combination treatment with BRAF plus MEK inhibitors and immune checkpoint therapy in BRAFV600 mutation-positive advanced or metastatic melanoma. Methods IMspire150 was a randomised, double-bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cf2a3be6d2159c5601451efc7ffdca2
https://doi.org/10.1016/s0140-6736(20)30934-x
https://doi.org/10.1016/s0140-6736(20)30934-x
Autor:
Hannah G, Rosenblum, Stephen C, Hadler, Danielle, Moulia, Tom T, Shimabukuro, John R, Su, Naomi K, Tepper, Kevin C, Ess, Emily Jane, Woo, Adamma, Mba-Jonas, Meghna, Alimchandani, Narayan, Nair, Nicola P, Klein, Kayla E, Hanson, Lauri E, Markowitz, Melinda, Wharton, Veronica V, McNally, José R, Romero, H Keipp, Talbot, Grace M, Lee, Matthew F, Daley, Sarah A, Mbaeyi, Sara E, Oliver
Publikováno v:
Morbidity and Mortality Weekly Report
In December 2020, the Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUAs) for Pfizer-BioNTech and Moderna COVID-19 vaccines, and in February 2021, FDA issued an EUA for the Janssen (JohnsonJohnson) COVID-19 vaccine. After ea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d80322bc82162ea705f777cc42710a37
https://pubmed.ncbi.nlm.nih.gov/34383735
https://pubmed.ncbi.nlm.nih.gov/34383735
Autor:
H. Wakelee, N. Altorki, E. Felip, E. Vallieres, I.O. Vynnychenko, A. Akopov, A. Martinez-Marti, A. Chella, I. Bondarenko, S. Sugawara, Y. Fan, H. Kenmotsu, Y.-M. Chen, Y. Deng, F. Wu, V. McNally, E. Bennett, B.J. Gitlitz, C. Zhou
Publikováno v:
Journal of Thoracic Oncology. 17:S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8573b85597e2ee07916cfea08237f9ee
https://doi.org/10.1016/j.jtho.2022.07.013
https://doi.org/10.1016/j.jtho.2022.07.013
Autor:
Jessica R, MacNeil, John R, Su, Karen R, Broder, Alice Y, Guh, Julia W, Gargano, Megan, Wallace, Stephen C, Hadler, Heather M, Scobie, Amy E, Blain, Danielle, Moulia, Matthew F, Daley, Veronica V, McNally, José R, Romero, H Keipp, Talbot, Grace M, Lee, Beth P, Bell, Sara E, Oliver
Publikováno v:
Morbidity and Mortality Weekly Report
On February 27, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Janssen COVID-19 (Ad.26.COV2.S) vaccine (Janssen Biotech, Inc., a Janssen Pharmaceutical company, JohnsonJohnson; New Brunswick, New Jers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::90a36416e5cc4941d62a0619cecf5c48
https://pubmed.ncbi.nlm.nih.gov/33914723
https://pubmed.ncbi.nlm.nih.gov/33914723
Autor:
V. Mcnally, Eric Vallières, Elizabeth Bennett, V. Moiseyenko, Heather A. Wakelee, J. Fang, Yun-Hyeon Kim, R. Vereshchako, Maurice Pérol, Yu Deng, F. Wu, Encarnação Teixeira, M. Tao, C. Zhou, Barbara J. Gitlitz, A. Smolin, Enriqueta Felip, Nasser K. Altorki, W. Schütte, A. Rittmeyer
Publikováno v:
Journal of Thoracic Oncology. 16:S845-S846
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4651a344339af2c44ca77dc232edf9a0
https://doi.org/10.1016/j.jtho.2021.08.031
https://doi.org/10.1016/j.jtho.2021.08.031
Autor:
Alexandru Eniu, V. McNally, Ž. Zvirbule, Jung Ho Sohn, Yibing Yan, S.-B. Kim, Matthew Wongchenko, Adam Brufsky, David Miles, Saibah Chohan, Jeroen Mebis, Sherene Loi, R. Amin
Background: Resistance to standard chemotherapy in metastatic triple-negative breast cancer (mTNBC) is associated with upregulation of the mitogen-activated protein kinase (MAPK) pathway. Cobimetinib, an MAPK/extracellular signal-regulated kinase (ME
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd79d91b0da371afcc23e33953fb7318
http://hdl.handle.net/1942/34426
http://hdl.handle.net/1942/34426
